Intravaginal hormonal contraception for women of reproductive age with excessive body mass
DOI:
https://doi.org/10.14739/2310-1210.2015.6.57019Keywords:
Contraception, Intravaginal Hormonal Ring, Excessive Body MassAbstract
There are a number of disadvantages inherent in all oral hormonal contraceptives: need for daily administration, fluctuations of hormone levels throughout the day, metabolism in the gastrointestinal tract, the effect of the first passage through the liver. All this became a prerequisite to the creation of prolonged oral hormonal methods of contraception, which would be devoid of these shortcomings. One of such method of hormonal contraception is intravaginal hormonal system.
The aim was to determine the safety and efficacy of its use in women of reproductive age with overweight. 43 women were included. State of lipid metabolism, changes of the hemostatic system, blood pressure and weight fluctuations in the past 6 months of using intravaginal hormonal contraceptive system were studied.
Results. It is established that hormonal intravaginal contraceptive ring gives minimal metabolic effects.
Conclusion. This suggests that this ring can be used successfully in patients with excessive body mass, because there is no effect of the ring on hemostasis, lipid metabolism and body weight.
References
Almazov, V. A., Blagosklonnaya, Ya. V., Shlyakhto, E. V., & Krasil'nikova, E. I. (1999) Metabolicheskij serdechno-sosudistyj sindrom [Metabolic cardiovascular syndrome]. Saint Petersburg. [in Russian].
Dedov, I. I., Melnichenko, G. A., & Romantsova, T. I. (2004) Patogeneticheskie aspekty ozhireniya [Pathogenetic aspects of obesity]. Ozhirenie i metabolizm, 1, 3–9. [in Russian].
Vsesvitnia orhanizatsiia okhorony zdorovia (2006) Kryterii pryiniatnosti vykorystannia metodiv kontratseptsii [Eligibility criteria of contraceptive use], (Issue 3, 2004 r.). Kyiv : Morion. [in Ukrainian].
Prilepskaya, V. M., & Tsallagov, E. V. (2004) Ginekologicheskaya e′ndokrinologiya [Gynecological endocrinology]. Moscow. [in Russian].
Svetlakov, A. V, Yamanova, M. V., Filippov, O. S., & Malakhova, N. A. (2001) Leptin i lipidnyj spektr krovi u zhenshchin s raznymi tipami ozhireniya [Leptin and blood lipid spectrum in women with different types of obesity]. Problemy reprodukcii, 6, 33–35. [in Russian].
Martins, J.M., Carreiras, F., Falcao, J., Afonso, A., da Costa, J.C. (1998) Dyslipidaemia in female overweight and obese patients. Relation to anthropometric and endocrine factors. International Journal of Obesity, 22(2), 164–170. doi: 10.1038/sj.ijo.0800557.
Roberts, L., & Haycox, A. (1999) Obesity. About the size of it. Health Serv J, 109(5662), 28–91.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
